Cargando…

Targeted BRAF Inhibitor Therapy Induces Remission of Unresectable Ampullary Adenocarcinoma

Detalles Bibliográficos
Autores principales:	Rego, Rayburn, Safar, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Image
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433074/ https://www.ncbi.nlm.nih.gov/pubmed/36061246 http://dx.doi.org/10.14309/crj.0000000000000844

Ejemplares similares

Peritoneal Loose Body in a Patient With Ampullary Adenocarcinoma
por: Pradeep, A.V., et al.
Publicado: (2021)

Unresectable cutaneous metastatic tumor in the arm that underwent complete remission after radiotherapy
por: Oike, Takahiro, et al.
Publicado: (2020)

Ampullary tumor presenting as acute cholangitis
por: Dadhich, Sunil, et al.
Publicado: (2014)

Ampullary adenocarcinoma – differentiation matters
por: Schirmacher, Peter, et al.
Publicado: (2008)

An Intriguing Cause of Intractable Nausea and Vomiting
por: Girotra, Mohit, et al.
Publicado: (2013)

An Unusual Cause of Acute Pancreatitis: Intraductal Tubulovillous Ampullary Adenoma
por: Vangimalla, Shiva Shankar, et al.
Publicado: (2020)

Excellent response to oral Metronomic chemotherapy in unresectable adenocarcinoma of external auditory canal
por: Noronha, Vanita, et al.
Publicado: (2015)

Histologic subtyping of ampullary carcinoma for targeted therapy
por: Hong, Seung-Mo
Publicado: (2021)

Identification of targetable BRAF ΔN486_P490 variant by whole-genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma
por: Wrzeszczynski, Kazimierz O., et al.
Publicado: (2019)

Mucins Differently Expressed in Various Ampullary Adenocarcinomas
por: Wang, Tao, et al.
Publicado: (2011)

Mediastinal lymphadenopathy in ampullary adenocarcinoma: not always metastatic
por: Rao, Chalapathi A.S., et al.
Publicado: (2012)

Ampullary Adenocarcinoma Causing Small Intestinal Obstruction
por: Abudalou, Mohammad, et al.
Publicado: (2020)

Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma
por: Shelledy, Lindsay, et al.
Publicado: (2015)

BRAF/MEK inhibitor-induced remission of primary cutaneous myoepithelial carcinoma after local recurrence
por: Guidry, Jacqueline, et al.
Publicado: (2020)

Rare Orbital Metastasis Originating from Ampullary Adenocarcinoma
por: Tsai, Yung-En, et al.
Publicado: (2021)

Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma
por: Park, Woo Daniel, et al.
Publicado: (2015)

Machine learning models for predicting survival in patients with ampullary adenocarcinoma
por: Huang, Tao, et al.
Publicado: (2022)

Coexistent Ampullary Squamous Cell Carcinoma with Adenocarcinoma of the Pancreatic Duct
por: Pathak, Gayatri S., et al.
Publicado: (2011)

HER-2-Positive Ampullary Adenocarcinoma: A Case Report
por: O'Hayer, Kevin, et al.
Publicado: (2015)

A Complex Diagnosis of Ampullary Adenocarcinoma Presenting As Decompensated Cirrhosis
por: Iqbal, Humzah, et al.
Publicado: (2023)

Pathological complete response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with unresectable BRAF V600E-mutant malignant melanoma of the gallbladder
por: Yu, Zhou, et al.
Publicado: (2018)

Peri-Ampullary Metastasis From Endometrial Adenocarcinoma: A Rare Etiology of Obstructive Jaundice
por: Ahmmad, Eimad, et al.
Publicado: (2019)

Usefulness of a gel immersion-assisted EUS-guided fine-needle aspiration/biopsy for ampullary lesions (with videos)
por: Minoda, Yosuke, et al.
Publicado: (2021)

Metastatic ampullary adenocarcinoma in exfoliative sputum cytology: A rare presentation
por: Roy, Maitrayee, et al.
Publicado: (2015)

Novel method for evaluating the indication for endoscopic papillectomy in patients with ampullary adenocarcinoma
por: Yamamoto, Kenjiro, et al.
Publicado: (2021)

A Rare Case of Metastatic Ampullary Adenocarcinoma Following the Whipple Procedure
por: Kaliounji, Aboud, et al.
Publicado: (2023)

Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients
por: Salzmann, Martin, et al.
Publicado: (2020)

Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study
por: Narang, Amol K, et al.
Publicado: (2011)

Spontaneous Remission of Isaacs’ Syndrome
por: Uslu, Sadettin, et al.
Publicado: (2019)

Restoring Radioiodine Uptake in BRAF V600E–Mutated Papillary Thyroid Cancer
por: Huillard, Olivier, et al.
Publicado: (2017)

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma
por: Overman, Michael J., et al.
Publicado: (2016)

Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group
por: Vranic, Semir, et al.
Publicado: (2022)

Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma
por: Oflas, Damla, et al.
Publicado: (2023)

Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
por: Uslu, Ugur, et al.
Publicado: (2023)

Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas
por: Saito, Hiroya, et al.
Publicado: (2008)

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study
por: Stege, Henner, et al.
Publicado: (2021)

Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive
por: Ghate, Sameer, et al.
Publicado: (2019)

BRAF(V600E)-Driven Lung Adenocarcinoma Requires Copper to Sustain Autophagic Signaling and Processing
por: Tsang, Tiffany, et al.
Publicado: (2022)

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy
por: Sun, James, et al.
Publicado: (2018)

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF-Mutated mCRC
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nhqtts6tc9veq892pk8sd4k67t